Navigation Links


Thromboembolism at Biology News

Thromboembolism at Biology Products
Thromboembolism at Biology Technology
Thromboembolism at Medicine News

ARIXTRA drug for venous thromboembolism

Venous thromboembolism is a complication causing increased bleeding which occurs after an orthopedic surgery procedure. // Professor Clifford W. Colwell has reported in the Journal of Arthroplasty that by giving a dose of ARIXTRA drug to these patients who underwent orthopedic surgery the complications and amount of bleeding decreased. ARIXTRA drug which is called as FLEXTRA (Flexibili...

Researchers Find That Thromboembolism Can Be Safely Treated At Home

Researchers have stated to find in their study that blood clots can be effectively managed at the homes of the patients.// According to a study that was led by Clive Kearon, professor of medicine at McMaster University that has been published in the August 23 issue of JAMA, The Journal of the American Medical Association the treatment of blood clots in the deep veins of the legs or th...

New Guidelines for Diagnosis of Venous Thromboembolism

AAFP and ACP have released new clinical practice guidelines for diagnosis and management of venous thromboembolism.// Venous thromboembolism is a condition that causes clotting in the veins. Key elements of the diagnosis guideline include the use of clinical prediction rules to establish pretest probability of deep vein thrombosis or pulmonary embolism in a patient before...
Thromboembolism at Medicine Products

Venous Thromboembolism (VTE), Qualitative

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Thromboembolism at Medicine Technology

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Rivaroxaban, a New Oral, Once-Daily Direct Factor Xa Inhibitor,Shows a Significant Reduction in Deep Vein Thrombosis and PulmonaryEmbolism Compared with Enoxaparin with Similarly Low BleedingRates GENEVA, July 8, 2007 - Late-breaking Phase III clinical trialdata presented today at the XXI International Society on Thrombosisand Haemostasis (ISTH) Congress demonstrate that once-daily...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

EXCLAIM is the First International Study to Show That ExtendedThromboprophylaxis Reduces VTE Risk in Acutely-ill Medical PatientsWith a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventisannounced today the results of the EXCLAIM (EXtended CLinicalprophylaxis in Acutely Ill Medical patients) study, which showedthe benefit of extended prophylaxi...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

GENEVA--(BUSINESS WIRE)--Jul 8, 2007 - Late-breaking Phase IIIclinical trial data presented today at the XXI InternationalSociety on Thrombosis and Haemostasis (ISTH) Congress demonstratethat once-daily rivaroxaban achieved superior efficacy in theprevention of venous thromboembolism (VTE) in patients undergoingknee replacement surgery in a head-to-head comparison withenoxaparin, the curren...

The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke

Risk of Having a Venous ThromboEmbolism (VTE) is Reduced by aSignificant 43% in Acute Ischemic Stroke Patients Treated WithClexane(R) / Lovenox(R) BRIDGEWATER, N.J., April 20, 2007 /PRNewswire-FirstCall/ --Sanofi-aventis announced the publication of the PREVAIL (Preventionof VTE after Acute Ischemic Stroke with LMWH Enoxaparin) trial inthe April 21st issue of The Lancet. The results of th...

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

Data to be Presented at the XXI Congress of the InternationalSociety on Thrombosis and Haemostasis SOUTH SAN FRANCISCO, Calif., April 04, 2007 /PRNewswire/ --Portola Pharmaceuticals, Inc. today announced that it has receivedpositive results from EXPERT, a Phase II study of its oral FactorXa inhibitor, PRT054021, for the prevention of venousthromboembolism (VTE) following total knee replac...
Thromboembolism at Medicine Dictionary

Thromboembolism

travels to the <a...
Other TagsAnGesAnGesAnGes
(Date:12/2/2008)... UCSF Medical Center ranks No. 1 nationw... are treated using balloon angioplasty, according ...). , (Vocus) December 2, ... for the speed with which heart attack patients ar...the National Cardiovascular Data Registry (NCDR). ...
(Date:12/2/2008)... United American Healthc... provides comprehensive healthcare,management ser... today,announced that its Board of Directors has ...the Company to repurchase up to $1.0 million of it...allows for the Company,s common shares to be purch...
(Date:12/2/2008).... 2 In an open letter t...on of Homes and Services for the Aging (AAHSA) Pre...s that the Obama administration can make both shor...e way America cares for its most vulnerable people...nd the Nation,s Work Force: Create Jobs in Aging S...
(Date:12/2/2008)...ients are having the procedure, study says , ...with the most common form of epilepsy who don,t re..., and dramatically improved quality of life at tha..., That,s the finding of a new study that relied o...ery of the temporal lobe region for people with te...
Breaking Medicine News(10 mins):Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3
(Date:12/1/2008)...mber 1, 2008) The basic molecules that make up al..."handedness," similar to the way people are right-...luence on the chemistry and molecular interactions...rom the elementary building blocks of matter is on...cientists at the U.S. Department of Energy,s Argon...
(Date:12/1/2008)...er issue of the Journal of the American Dietetic ... the everyday eating habits of consumers. Research...r meal choice and methods for adding healthier foo...he December 2008 Journal of the American Dietetic...taurants: Reported Reasons among Frequent Consumer...
(Date:12/1/2008)...lays an essential role in protecting us from disea...ist Suzanne van Helden discovered that before dend...r sticky feet. This helps them to move much faster...earch of antigens. After exposure to such antigens...g this maturation the dendritic cells migrate to t...
(Date:12/1/2008)...ude Children,s Research Hospital have discovered t... to change its identity that it requires the const...it. , The researchers showed that Prox1 acts as...o reprogram a specialized type of cell, called a l... active Prox1, the LEC actually loses its identity...
Breaking Biology News(10 mins):Argonne scientists discover possible mechanism for creating 'handedness' in biological molecules 2News from the December 2008 Journal of the American Dietetic Association 2Immune cells reveal fancy footwork 2Reprogrammable cell type depends on a single gene to keep its identity 2See to It That New Years Eve Is Safe 8943 1See to It That New Years Eve Is Safe 8943 2SPX Corporation Completes Acquisition of APV 8939 1SPX Corporation Completes Acquisition of APV 8939 2Drug Safety Tainted Food Among Years Top Health Stories 8936 1Drug Safety Tainted Food Among Years Top Health Stories 8936 2Drug Safety Tainted Food Among Years Top Health Stories 8936 3Drug Safety Tainted Food Among Years Top Health Stories 8936 4Annals of Internal Medicine tip sheet for Jan 1 2008 issue 8934 1Annals of Internal Medicine tip sheet for Jan 1 2008 issue 8934 2
Other Contentslistlistlistlistlistlistlistlistlistpotentiationpotentiationtermtermtermtermtermtermtermtermtermtermlonglonglonglonglonglonglonglonglonglonglocuslocuslocuslocuslocuslocuspasteurlunglunglunglunglunglunglunglunglunghypothesishypothesishypothesishypothesishypothesishypothesis